10,472
Total Claims
$940K
Drug Cost
729
Beneficiaries
$1,289
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-94%
Opioid rate vs peers
0.2% vs 2.6% avg
+21%
Cost per patient vs peers
$1,289 vs $1,068 avg
+23%
Brand preference vs peers
11.1% vs 9.0% avg
Opioid Prescribing
0.2%
Opioid Rate
17
Opioid Claims
$107
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
89% generic
Brand: 1,150 claims · $699K
Generic: 9,246 claims · $236K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 69 | $93K |
| Rivaroxaban | 78 | $87K |
| Apixaban | 54 | $60K |
| Semaglutide | 48 | $48K |
| Dapagliflozin Propanediol | 52 | $44K |
| Sacubitril/Valsartan | 31 | $39K |
| Tirzepatide | 21 | $27K |
| Fluticasone/Umeclidin/Vilanter | 21 | $25K |
| Fluticasone Propion/Salmeterol | 47 | $20K |
| Dulaglutide | 11 | $19K |
| Insulin Detemir | 36 | $18K |
| Exenatide Microspheres | 17 | $16K |
| Rosuvastatin Calcium | 144 | $15K |
| Sitagliptin Phosphate | 13 | $14K |
| Fluticasone/Vilanterol | 31 | $13K |
Prescribing Profile
Patient Profile
74
Avg Age
49%
Female
1.25
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data